Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VENLAFAXINE Cause Intentional product use issue? 210 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 210 reports of Intentional product use issue have been filed in association with VENLAFAXINE (Venlafaxine Hydrochloride). This represents 0.4% of all adverse event reports for VENLAFAXINE.

210
Reports of Intentional product use issue with VENLAFAXINE
0.4%
of all VENLAFAXINE reports
19
Deaths
45
Hospitalizations

How Dangerous Is Intentional product use issue From VENLAFAXINE?

Of the 210 reports, 19 (9.0%) resulted in death, 45 (21.4%) required hospitalization, and 17 (8.1%) were considered life-threatening.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VENLAFAXINE. However, 210 reports have been filed with the FAERS database.

What Other Side Effects Does VENLAFAXINE Cause?

Drug ineffective (5,408) Toxicity to various agents (3,917) Nausea (2,989) Completed suicide (2,929) Headache (2,668) Dizziness (2,426) Off label use (2,310) Overdose (2,220) Intentional overdose (2,187) Fatigue (2,153)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280)

Which VENLAFAXINE Alternatives Have Lower Intentional product use issue Risk?

VENLAFAXINE vs VENTAVIS VENLAFAXINE vs VENTOLIN VENLAFAXINE vs VENTOLIN HFA VENLAFAXINE vs VERAPAMIL VENLAFAXINE vs VERICIGUAT

Related Pages

VENLAFAXINE Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue VENLAFAXINE Demographics